Showing 791-800 of 1426 results for "".
The Skinny on Non-Invasive Fat Reduction: The Case for an a la Carte Approach to Body Contouring
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-skinny-on-non-invasive-fat-reduction-the-case-for-an-a-la-carte-approach-to-body-contouring/20978/As the business of body contouring explodes, physicians—and patients—must consider the treatment options.CSF Faculty: Sunscreen Picks
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2021/csf-faculty-sunscreen-picks/23490/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21460/The Role of GLP-1RAs in Treating Inflammatory Dermatologic Diseases
https://practicaldermatology.com/issues/novemberdecember-2025/the-role-of-glp-1ras-in-treating-inflammatory-dermatologic-diseases/48899/Herein, we review the benefits and risks of GLP-1RAs with a focus on these 3 chronic inflammatory conditions.Therapeutic Advances in the Topical Management of Acne
https://practicaldermatology.com/issues/supplements/therapeutic-advances-in-the-topical-management-of-acne/21618/A.G.E. Interrupter Advanced: Newest Innovative Anti-Aging Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/age-interrupter-advanced-newest-innovative-anti-aging-cream/23930/Assessment of Superficially-placed Microaliquots of Small-particle HA
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/assessment-of-superficially-placed-microaliquots-of-small-particle-ha/23611/A prospective, open-label clinical trial assesses micro-injections of transparent hyaluronic acid gel for cheek rejuvenation.Cosmetics Challenge
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge/21793/DermWireTV: Zoryve Approved; New SDPA President; Project Determi-Nation; Stelara for Pediatric PsA
https://practicaldermatology.com/topics/psoriasis/dermwiretv-zoryve-approved-new-sdpa-president-project-determi-nation-stelara-for-pediatric-psa/20115/FDA has approved Zoryve from Arcutis Biotherapeutics for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. The novel formulation of roflumilast cream 0.3% is indicated for once-daily application. Stelara (ustekinumab) from Janssen is now approveColloidal Oatmeal in the Treatment of Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/colloidal-oatmeal-in-the-treatment-of-atopic-dermatitis/23338/Is this plant-based intervention an effective treatment alternative?